Company: HUM
Filing Date: 2025-03-28
Form Type: 424B5
Source: 0001628280-25-015313
Chunk: 43

Company: HUMANA INC
Filing Date: 2025-03-28
Form: 424B5
Chunk 43
---
 |
| Barclays Capital Inc.          |     |                          |  62,500,000 |
| BofA Securities, Inc.          |     |                          |  12,500,000 |
| Mizuho Securities USA LLC      |     |                          |  12,500,000 |
| U.S. Bancorp Investments, Inc. |     |                          |  12,500,000 |
| Total                          |     | $                        | 250,000,000 |

The underwriters have agreed, subject to the terms and conditions of the underwriting agreement, to purchase all of the additional 2031 notes being sold if any of the additional 2031 notes being sold are purchased. In the event of a default by an underwriter, the underwriting agreement provides that, in certain circumstances, the purchase commitments of the nondefaulting underwriters may be increased or the underwriting agreement may be terminated.

We have agreed to indemnify the several underwriters against certain liabilities, including certain liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities.

The additional 2031 notes are being offered by the several underwriters, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of certain legal matters by counsel for the underwriters and certain other conditions. The underwriters reserve the right to withdraw, cancel or modify such offer and to reject orders in whole or in part.

The underwriters propose initially to offer the additional 2031 notes to the public at the initial public offering price set forth on the cover page of this prospectus supplement, and to certain dealers at such price less a concession not in excess of 0.400% of the principal amount of the additional 2031 notes. The underwriters may allow, and such dealers may reallow, a discount not in excess of 0.200% of the principal amount of the additional 2031 notes to certain other dealers. After the initial public offering, the public offering price, concession and discount may be changed.

We estimate that the expenses of the offering, exclusive of the underwriting discount, will be approximately $1.2 million and will be payable by us.

The additional 2031 notes will become part of the same series as our outstanding 5.375% Senior Notes due 2031, $1,250 million aggregate principal amount of which were originally issued on March 13, 2024. There may cease